Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the Common Stock, par value $0.01 per share, of Enzon Pharmaceuticals, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: April 16, 2020
/s/ Jonathan Couchman | |
| JONATHAN Couchman |
| XSTELOS CORP. | |||
| By: | /s/ Jonathan Couchman | ||
| Name: | Jonathan Couchman | ||
| Title: | President and Chief Executive Officer | ||
| COUCHMAN FAMILY FUND | |||
| By: | /s/ Jonathan Couchman | ||
| Name: | Jonathan Couchman | ||
| Title: | Trustee | ||
| myrexis, inc. | |||
| By: | /s/ Jonathan Couchman | ||
| Name: | Jonathan Couchman | ||
| Title: | President and Chief Executive Officer | ||
